Taiwan Investing Millions To Become Regional Pharma R&D Hub And Gateway To Mainland China
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - As part of a four-part plan to develop biotech into its next "trillion-dollar industry," Taiwan is investing hundreds of millions of dollars into the sector and developing specialized science parks and clusters
You may also be interested in...
Taiwan's Biotech Sector Plan Stalled By Funding Limitations, Wary Investors
HONG KONG - Taiwan's aspirations to become a regional biotech powerhouse have been delayed in the last year by overly stringent requirements and a lack of professionals to undertake two key portions of a four-part industry development blueprint
Taiwan's Biotech Sector Plan Stalled By Funding Limitations, Wary Investors
HONG KONG - Taiwan's aspirations to become a regional biotech powerhouse have been delayed in the last year by overly stringent requirements and a lack of professionals to undertake two key portions of a four-part industry development blueprint
Taiwan Eyes Cross-strait Biotech Cooperation with China
SHANGHAI - Taiwan hopes to strengthen cooperation with mainland China in the development of the biotechnology and medical device industry, according to Taiwan's Vice Minister of Economic Affairs Huang Chuang-chiou